Eptinezumab Safe, Effective for Migraine Prevention Eptinezumab Safe, Effective for Migraine Prevention

A single dose of eptinezumab, which targets calcitonin gene-related peptide, provides rapid efficacy lasting up to 3 months in the prevention of chronic migraine, say PROMISE-2 investigators.Medscape Medical News

Source: Medscape Medical News Headlines - June 21, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news